Prevention of Suicidal Behaviour With Telemedicine Techniques

NCT ID: NCT03043040

Last Updated: 2018-04-09

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 651 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2014-07-01
• Study Completion Date: 2017-03-31

Brief Summary

This is a multicenter controlled intervention study that aims to assess the efficacy of a telephone follow-up program for the prevention of suicidal behavior in adults discharged from general hospitals after a suicide attempt.

The hypothesis is that the implementation of this program is associated with reduced rates of suicide reattempts in these patients and also with delayed reattempts in them.

Detailed Description

Justification: Suicide is a global public health concern and is the leading cause of avoidable death in the Basque Country (Spain). The use of telemedicine techniques applied to high risk patients has shown to be useful in the prevention of suicide and suicidal behavior.

Objectives: To assess the efficacy of a telephone follow-up program for the prevention of suicidal behavior in patients who recently attempted suicide.

Design: This is a multicenter, prospective intervention study, non-randomized and with control group.

Method: A sample of adults discharged from 2 general hospitals after a suicide attempt are enrolled in a telephone follow-up program which is added to their usual treatment (TAU). The program consists of 5 short calls made by nurses during 6 months. The calls are intended to: 1) Assess the risk of suicide in that moment, 2) Improve patient's adherence to treatments, and 3) Provide general psychoeducation guidelines. The control group is composed of patients discharged from a third general hospital after a suicide attempt. These receive TAU but are not enrolled in the telephone follow-up.

Evaluation: All patients are followed during 12 months. Main outcome measures include the percentage of patients that make a second attempt and the average time to reattempt.

Patients sign and informed consent.

Conditions

Suicide, Attempted

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: NONE

Study Groups

Telephone follow up

Patients discharged from hospital A and B after a suicide attempt receive a protocolized telephone follow which is added to their usual treatment (TAU). Calls are made by nurses at weeks 1,2,4,12 and 24 after the index suicide attempt.

TAU: Includes whatever treatment the doctor decides to offer to that patient (psychopharmacology, psychotherapy etc).

Group Type: EXPERIMENTAL

Telephone follow up

Intervention Type: BEHAVIORAL

Already described in previous page

Treatment as usual

Intervention Type: BEHAVIORAL

Already described in previous page

Control

Patients discharged from hospital C after a suicide attempt receive treatment as usual (whatever treatment the doctor decides to offer to that patient: psychopharmacology, psychotherapy etc).

Group Type: ACTIVE_COMPARATOR

Treatment as usual

Intervention Type: BEHAVIORAL

Already described in previous page

Interventions

Telephone follow up

Already described in previous page

Intervention Type: BEHAVIORAL

Treatment as usual

Already described in previous page

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Adult patients discharged from a General Hospital after a suicide attempt and who live in the same health sector as the hospital.
• The suicide attempt must have been made within 24 hours prior to the appointment in the Emergency Service.

Exclusion Criteria

• Patient with severe cognitive difficulties and in general any self-injury in which the patient does not understand the meaning or potential consequences of such behavior.
• Patients in which a regular telephone contact is not possible.
• Patients in which the psychiatrist who evaluates the case deems inappropriate their inclusion.
• Patients who remain hospitalized 6 months after the attempt.

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Eusko Jaurlaritza

UNKNOWN

Sponsor Role: collaborator

Osakidetza

OTHER

Sponsor Role: lead

Responsible Party

Andrea Gabilondo

Principal Investigator

Responsibility Role: PRINCIPAL_INVESTIGATOR

Other Identifiers

2017AG01

Identifier Type: -

Identifier Source: org_study_id